• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早期加入糖尿病按绩效付费计划可减少新诊断的2型糖尿病患者预期寿命的损失。

Early Enrollment in Diabetes Pay-for-Performance Program Reduced Loss of Life Expectancy in Newly-Diagnosed Patients with Type 2 Diabetes Mellitus.

作者信息

Chen Yu-Ching, Wang Wei-Ming, Lin Boniface J, Wang Jung-Der, Ku Li-Jung Elizabeth

机构信息

Department of Public Health, College of Medicine, National Cheng Kung University, Tainan, Taiwan.

Department of Healthcare Administration and Medical Informatics, Kaohsiung Medical University, Kaohsiung, Taiwan.

出版信息

Diabetes Metab J. 2025 Sep;49(5):1051-1063. doi: 10.4093/dmj.2024.0507. Epub 2025 Mar 26.

DOI:10.4093/dmj.2024.0507
PMID:40134091
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12436039/
Abstract

BACKGRUOUND

Diabetes is associated with reduced lifespan. To explore pay-for-performance (P4P) program and life expectancy (LE), we investigated the impact of interval between diabetes diagnosis and enrollment in P4P program on loss-of-LE among patients with diabetes in Taiwan.

METHODS

From diabetes mellitus health database, which collected all newly-diagnosed patients with diabetes by calendar year, we selected patients, aged 40 to 64, with 503,662 in P4P group and 450,071 in non-P4P group, respectively, from 2004 to 2015, and followed them until the end of 2018 using Kaplan-Meier survival analysis. We simulated age-, gender-, and calendar yearmatched referents for each group through Monte Carlo method from Taiwan's vital statistics. We constructed a restricted cubic spline model on logit-transformed relative survival between each group and its corresponding matched referents, and applied a rolling-over algorithm month-by-month to extrapolate the survival function of each index group to lifetime to estimate the LE, which was subtracted from that of matched referents to obtain the loss-of-LE.

RESULTS

We found stratified analysis by interval showed that the earlier the enrollment, the lower the loss-of-LE, namely, 0.06±0.72 years for interval <1 year, 0.05±0.59 years for interval 1-4 years, 10.01±0.11 years for interval 5-9 years, and 12.77±0.14 years for interval 10-15 years, respectively (P<0.001), compared with 2.60±0.14 years for non-P4P group.

CONCLUSION

Early enrollment in the P4P program was associated with reduced loss-of-LE, indicating P4P might gain life if implemented early after diabetes diagnosis.

摘要

背景

糖尿病与寿命缩短有关。为了探究绩效薪酬(P4P)计划与预期寿命(LE)之间的关系,我们调查了台湾糖尿病患者从糖尿病诊断到加入P4P计划的时间间隔对LE损失的影响。

方法

从糖尿病健康数据库中,该数据库按日历年收集所有新诊断的糖尿病患者,我们分别选取了2004年至2015年年龄在40至64岁之间的患者,P4P组有503,662例,非P4P组有450,071例,并使用Kaplan-Meier生存分析对他们进行随访直至2018年底。我们通过蒙特卡罗方法从台湾人口动态统计数据中为每组模拟年龄、性别和日历年匹配的对照。我们在每组与其相应匹配对照之间的对数转换相对生存上构建了一个受限立方样条模型,并逐月应用滚动算法将每个指标组的生存函数外推至终生以估计LE,从匹配对照的LE中减去该LE以获得LE损失。

结果

我们发现按时间间隔进行的分层分析表明,加入时间越早,LE损失越低,即时间间隔<1年时为0.06±0.72年,时间间隔1 - 4年时为0.05±0.59年,时间间隔5 - 9年时为10.01±0.11年,时间间隔10 - 15年时为12.77±0.14年(P<0.001),而非P4P组为2.60±0.14年。

结论

早期加入P4P计划与降低LE损失相关,表明P4P计划如果在糖尿病诊断后早期实施可能会延长寿命。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0838/12436039/59c57ed495dd/dmj-2024-0507f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0838/12436039/8df6bc346d44/dmj-2024-0507f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0838/12436039/52073e951dde/dmj-2024-0507f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0838/12436039/227ed30e91cd/dmj-2024-0507f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0838/12436039/59c57ed495dd/dmj-2024-0507f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0838/12436039/8df6bc346d44/dmj-2024-0507f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0838/12436039/52073e951dde/dmj-2024-0507f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0838/12436039/227ed30e91cd/dmj-2024-0507f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0838/12436039/59c57ed495dd/dmj-2024-0507f4.jpg

相似文献

1
Early Enrollment in Diabetes Pay-for-Performance Program Reduced Loss of Life Expectancy in Newly-Diagnosed Patients with Type 2 Diabetes Mellitus.早期加入糖尿病按绩效付费计划可减少新诊断的2型糖尿病患者预期寿命的损失。
Diabetes Metab J. 2025 Sep;49(5):1051-1063. doi: 10.4093/dmj.2024.0507. Epub 2025 Mar 26.
2
Impact of pay-for-performance program on postoperative infection and revision risk in diabetic patients with hip replacement: a Taiwanese Cohort Study.绩效薪酬计划对糖尿病髋关节置换患者术后感染及翻修风险的影响:一项台湾队列研究
Int J Qual Health Care. 2025 Jul 4;37(3). doi: 10.1093/intqhc/mzaf051.
3
Effects of individual and neighborhood social risks on diabetes pay-for-performance program under a single-payer health system.个体和社区社会风险对单一支付方健康体系下糖尿病按绩效付费计划的影响。
Soc Sci Med. 2023 Jun;326:115930. doi: 10.1016/j.socscimed.2023.115930. Epub 2023 Apr 26.
4
Is the pay-for-performance program associated with better quality of life among type 2 diabetes patients, including those with gastrointestinal conditions, in Taiwan? A cross-sectional survey.在台湾,绩效薪酬计划是否与2型糖尿病患者(包括患有胃肠道疾病的患者)更好的生活质量相关?一项横断面调查。
PLoS One. 2025 Aug 22;20(8):e0328910. doi: 10.1371/journal.pone.0328910. eCollection 2025.
5
Examining the Long-term Spillover Effects of a Pay-for-Performance Program in a Healthcare System That Lacks Referral Arrangements.考察在缺乏转诊安排的医疗系统中绩效薪酬计划的长期溢出效应。
Int J Health Policy Manag. 2023;12:7571. doi: 10.34172/ijhpm.2023.7571. Epub 2023 Oct 9.
6
Impact of early interruption from pay-for-performance program on progression and medical utilization for patients with early chronic kidney disease.早期中断绩效付费计划对早期慢性肾脏病患者病情进展及医疗利用的影响。
Int J Qual Health Care. 2025 Jul 4;37(3). doi: 10.1093/intqhc/mzaf075.
7
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
8
Payment methods for outpatient care facilities.门诊护理机构的支付方式。
Cochrane Database Syst Rev. 2017 Mar 3;3(3):CD011153. doi: 10.1002/14651858.CD011153.pub2.
9
Are Current Survival Prediction Tools Useful When Treating Subsequent Skeletal-related Events From Bone Metastases?当前的生存预测工具在治疗骨转移后的骨骼相关事件时有用吗?
Clin Orthop Relat Res. 2024 Sep 1;482(9):1710-1721. doi: 10.1097/CORR.0000000000003030. Epub 2024 Mar 22.
10
Hybrid closed-loop systems for managing blood glucose levels in type 1 diabetes: a systematic review and economic modelling.用于管理1型糖尿病患者血糖水平的混合闭环系统:系统评价与经济建模
Health Technol Assess. 2024 Dec;28(80):1-190. doi: 10.3310/JYPL3536.

引用本文的文献

1
Start Early, Do It Well: Implications of a National Diabetes Care Quality Assessment Program for Life Expectancy.早开始,做好它:国家糖尿病护理质量评估计划对预期寿命的影响。
Diabetes Metab J. 2025 Sep;49(5):987-989. doi: 10.4093/dmj.2025.0670. Epub 2025 Sep 1.

本文引用的文献

1
Participation and Outcomes among Disabled and Non-Disabled People in the Diabetes Pay-for-Performance Program.糖尿病绩效付费项目中残疾人和非残疾人的参与情况及结果
Healthcare (Basel). 2023 Oct 16;11(20):2742. doi: 10.3390/healthcare11202742.
2
Life expectancy associated with different ages at diagnosis of type 2 diabetes in high-income countries: 23 million person-years of observation.在高收入国家,不同发病年龄的 2 型糖尿病患者的预期寿命:2300 万人年的观察结果。
Lancet Diabetes Endocrinol. 2023 Oct;11(10):731-742. doi: 10.1016/S2213-8587(23)00223-1. Epub 2023 Sep 11.
3
Long-term Effectiveness of the National Diabetes Quality Assessment Program in South Korea.
韩国国家糖尿病质量评估计划的长期效果。
Diabetes Care. 2023 Sep 1;46(9):1700-1706. doi: 10.2337/dc23-0444.
4
Impact of a diabetes pay-for-performance program on nonincentivized mental disorders: a panel study based on claims database analysis.糖尿病绩效薪酬计划对非激励性精神障碍的影响:基于索赔数据库分析的面板研究。
Cost Eff Resour Alloc. 2023 Jul 6;21(1):41. doi: 10.1186/s12962-023-00450-y.
5
Validation of diagnosis codes in healthcare databases in Taiwan, a literature review.台湾地区医疗数据库中诊断编码的验证:文献回顾。
Pharmacoepidemiol Drug Saf. 2023 Jul;32(7):795-811. doi: 10.1002/pds.5608. Epub 2023 Mar 27.
6
Comparison of Parametric Survival Extrapolation Approaches Incorporating General Population Mortality for Adequate Health Technology Assessment of New Oncology Drugs.纳入一般人群死亡率的参数生存外推方法比较,以充分评估新肿瘤药物的卫生技术评估。
Value Health. 2021 Sep;24(9):1294-1301. doi: 10.1016/j.jval.2021.03.008. Epub 2021 Apr 20.
7
Chronic care model in the diabetes pay-for-performance program in Taiwan: Benefits, challenges and future directions.台湾糖尿病按绩效付费计划中的慢性病照护模式:益处、挑战与未来方向。
World J Diabetes. 2021 May 15;12(5):578-589. doi: 10.4239/wjd.v12.i5.578.
8
Associations between attainment of incentivised primary care diabetes indicators and mortality in an English cohort.英国队列中初级保健糖尿病激励指标的达成情况与死亡率之间的关联。
Diabetes Res Clin Pract. 2021 Apr;174:108746. doi: 10.1016/j.diabres.2021.108746. Epub 2021 Mar 10.
9
Cost-effectiveness of percutaneous coronary intervention versus medical therapy in patients with acute myocardial infarction: real-world and lifetime-horizon data from Taiwan.经皮冠状动脉介入治疗与药物治疗对急性心肌梗死患者的成本效益比较:来自中国台湾的真实世界和终身时间范围数据。
Sci Rep. 2021 Mar 10;11(1):5608. doi: 10.1038/s41598-021-84853-y.
10
Savings of loss-of-life expectancy and lifetime medical costs from prevention of spinal cord injuries: analysis of nationwide data followed for 17 years.预防脊髓损伤所带来的预期寿命损失和终身医疗费用的节省:对17年全国数据的分析
Inj Prev. 2021 Dec;27(6):567-573. doi: 10.1136/injuryprev-2020-043943. Epub 2021 Jan 22.